• Something wrong with this record ?

Targeted sequencing and in vitro splice assays shed light on ABCA4-associated retinopathies missing heritability

Z. Corradi, M. Khan, R. Hitti-Malin, K. Mishra, L. Whelan, SS. Cornelis, ABCA4-Study Group, CB. Hoyng, K. Kämpjärvi, CCW. Klaver, P. Liskova, H. Stöhr, BHF. Weber, S. Banfi, GJ. Farrar, D. Sharon, J. Zernant, R. Allikmets, CM. Dhaenens, FPM. Cremers

. 2023 ; 4 (4) : 100237. [pub] 20230912

Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc24014616

Grant support
P30 EY019007 NEI NIH HHS - United States
R01 EY028203 NEI NIH HHS - United States
R01 EY028954 NEI NIH HHS - United States
R01 EY029315 NEI NIH HHS - United States

The ABCA4 gene is the most frequently mutated Mendelian retinopathy-associated gene. Biallelic variants lead to a variety of phenotypes, however, for thousands of cases the underlying variants remain unknown. Here, we aim to shed further light on the missing heritability of ABCA4-associated retinopathy by analyzing a large cohort of macular dystrophy probands. A total of 858 probands were collected from 26 centers, of whom 722 carried no or one pathogenic ABCA4 variant, while 136 cases carried two ABCA4 alleles, one of which was a frequent mild variant, suggesting that deep-intronic variants (DIVs) or other cis-modifiers might have been missed. After single molecule molecular inversion probes (smMIPs)-based sequencing of the complete 128-kb ABCA4 locus, the effect of putative splice variants was assessed in vitro by midigene splice assays in HEK293T cells. The breakpoints of copy number variants (CNVs) were determined by junction PCR and Sanger sequencing. ABCA4 sequence analysis solved 207 of 520 (39.8%) naive or unsolved cases and 70 of 202 (34.7%) monoallelic cases, while additional causal variants were identified in 54 of 136 (39.7%) probands carrying two variants. Seven novel DIVs and six novel non-canonical splice site variants were detected in a total of 35 alleles and characterized, including the c.6283-321C>G variant leading to a complex splicing defect. Additionally, four novel CNVs were identified and characterized in five alleles. These results confirm that smMIPs-based sequencing of the complete ABCA4 gene provides a cost-effective method to genetically solve retinopathy cases and that several rare structural and splice altering defects remain undiscovered in Stargardt disease cases.

Blueprint Genetics Espoo Finland

Department of Epidemiology Erasmus Medical Center Rotterdam the Netherlands

Department of Human Genetics Radboud University Medical Center Nijmegen the Netherlands

Department of Ophthalmology 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Department of Ophthalmology Columbia University New York NY USA

Department of Ophthalmology Erasmus Medical Center Rotterdam the Netherlands

Department of Ophthalmology Hadassah Medical Center Faculty of Medicine The Hebrew University of Jerusalem Jerusalem Israel

Department of Ophthalmology Radboud University Medical Center Nijmegen the Netherlands

Department of Pathology and Cell Biology Columbia University New York NY USA

Department of Precision Medicine University of Campania Luigi Vanvitelli Naples and Telethon Institute of Genetics and Medicine Pozzuoli Italy

Institute of Clinical Human Genetics University Hospital Regensburg Regensburg Germany

Institute of Human Genetics University of Regensburg Regensburg Germany

Institute of Molecular and Clinical Ophthalmology Basel Switzerland

Max Planck Institute for Psycholinguistics Nijmegen the Netherlands

Research Unit for Rare Diseases Department of Paediatrics and Adolescent Medicine 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

The School of Genetics and Microbiology Trinity College Dublin Dublin Ireland

University Lille Inserm CHU Lille U1172 LilNCog Lille Neuroscience and Cognition 59000 Lille France

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24014616
003      
CZ-PrNML
005      
20240905134407.0
007      
ta
008      
240725s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.xhgg.2023.100237 $2 doi
035    __
$a (PubMed)37705246
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Corradi, Zelia $u Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: zelia.corradi@radboudumc.nl
245    10
$a Targeted sequencing and in vitro splice assays shed light on ABCA4-associated retinopathies missing heritability / $c Z. Corradi, M. Khan, R. Hitti-Malin, K. Mishra, L. Whelan, SS. Cornelis, ABCA4-Study Group, CB. Hoyng, K. Kämpjärvi, CCW. Klaver, P. Liskova, H. Stöhr, BHF. Weber, S. Banfi, GJ. Farrar, D. Sharon, J. Zernant, R. Allikmets, CM. Dhaenens, FPM. Cremers
520    9_
$a The ABCA4 gene is the most frequently mutated Mendelian retinopathy-associated gene. Biallelic variants lead to a variety of phenotypes, however, for thousands of cases the underlying variants remain unknown. Here, we aim to shed further light on the missing heritability of ABCA4-associated retinopathy by analyzing a large cohort of macular dystrophy probands. A total of 858 probands were collected from 26 centers, of whom 722 carried no or one pathogenic ABCA4 variant, while 136 cases carried two ABCA4 alleles, one of which was a frequent mild variant, suggesting that deep-intronic variants (DIVs) or other cis-modifiers might have been missed. After single molecule molecular inversion probes (smMIPs)-based sequencing of the complete 128-kb ABCA4 locus, the effect of putative splice variants was assessed in vitro by midigene splice assays in HEK293T cells. The breakpoints of copy number variants (CNVs) were determined by junction PCR and Sanger sequencing. ABCA4 sequence analysis solved 207 of 520 (39.8%) naive or unsolved cases and 70 of 202 (34.7%) monoallelic cases, while additional causal variants were identified in 54 of 136 (39.7%) probands carrying two variants. Seven novel DIVs and six novel non-canonical splice site variants were detected in a total of 35 alleles and characterized, including the c.6283-321C>G variant leading to a complex splicing defect. Additionally, four novel CNVs were identified and characterized in five alleles. These results confirm that smMIPs-based sequencing of the complete ABCA4 gene provides a cost-effective method to genetically solve retinopathy cases and that several rare structural and splice altering defects remain undiscovered in Stargardt disease cases.
650    _2
$a lidé $7 D006801
650    _2
$a HEK293 buňky $7 D057809
650    _2
$a mutace $x genetika $7 D009154
650    12
$a makulární degenerace $x genetika $7 D008268
650    12
$a retinální dystrofie $x genetika $7 D058499
650    _2
$a sekvenční analýza $7 D017421
650    _2
$a ABC transportéry $x genetika $7 D018528
655    _2
$a časopisecké články $7 D016428
700    1_
$a Khan, Mubeen $u Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands; Max Planck Institute for Psycholinguistics, Nijmegen, the Netherlands
700    1_
$a Hitti-Malin, Rebekkah $u Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
700    1_
$a Mishra, Ketan $u Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
700    1_
$a Whelan, Laura $u The School of Genetics & Microbiology, Trinity College Dublin, Dublin, Ireland
700    1_
$a Cornelis, Stéphanie S $u Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
700    1_
$a Hoyng, Carel B $u Department of Ophthalmology, Radboud University Medical Center, Nijmegen, the Netherlands
700    1_
$a Kämpjärvi, Kati $u Blueprint Genetics, Espoo, Finland
700    1_
$a Klaver, Caroline C W $u Department of Ophthalmology, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands; Department of Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands; Institute of Molecular & Clinical Ophthalmology, Basel, Switzerland
700    1_
$a Liskova, Petra $u Research Unit for Rare Diseases, Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic; Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Stöhr, Heidi $u Institute of Human Genetics, University of Regensburg, Regensburg, Germany
700    1_
$a Weber, Bernhard H F $u Institute of Human Genetics, University of Regensburg, Regensburg, Germany; Institute of Clinical Human Genetics, University Hospital Regensburg, Regensburg, Germany
700    1_
$a Banfi, Sandro $u Department of Precision Medicine, University of Campania "Luigi Vanvitelli," Naples and Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy
700    1_
$a Farrar, G Jane $u The School of Genetics & Microbiology, Trinity College Dublin, Dublin, Ireland
700    1_
$a Sharon, Dror $u Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel
700    1_
$a Zernant, Jana $u Department of Ophthalmology, Columbia University, New York, NY, USA
700    1_
$a Allikmets, Rando $u Department of Ophthalmology, Columbia University, New York, NY, USA; Department of Pathology & Cell Biology, Columbia University, New York, NY, USA
700    1_
$a Dhaenens, Claire-Marie $u Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands; University Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille, France
700    1_
$a Cremers, Frans P M $u Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
710    2_
$a ABCA4-Study Group
773    0_
$w MED00209103 $t HGG advances $x 2666-2477 $g Roč. 4, č. 4 (2023), s. 100237
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37705246 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134401 $b ABA008
999    __
$a ok $b bmc $g 2144032 $s 1226482
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 4 $c 4 $d 100237 $e 20230912 $i 2666-2477 $m HGG advances $n HGG Adv $x MED00209103
GRA    __
$a P30 EY019007 $p NEI NIH HHS $2 United States
GRA    __
$a R01 EY028203 $p NEI NIH HHS $2 United States
GRA    __
$a R01 EY028954 $p NEI NIH HHS $2 United States
GRA    __
$a R01 EY029315 $p NEI NIH HHS $2 United States
LZP    __
$a Pubmed-20240725
Back

Find record

Citation metrics

Archiving options